Imprivata partners with DigiCert to streamline identity proofing workflows for electronic prescriptions

Imprivata and federally approved certificate authority DigiCert have announced a partnership to deliver a streamlined, fully integrated workflow for remote identity proofing to give customers options for meeting the evolving requirements of U.S. Drug Enforcement Agency (DEA) and state laws for electronic prescribing for controlled substances (EPCS).

The opioid abuse crisis has motivated the new Support for Patients and Communities Act, which includes an electronic prescribing requirement for controlled substance prescriptions for a covered part D drug under a prescription plan, according to the announcement. The companies also note that 13 states have passed legislation with full EPCS mandates. Practitioners must undergo an institutional or individual identity proofing process before they can be issued two-factor authentication credentials for EPCS order signing, according to DEA stipulations, and Imprivata Confirm ID provides Hands Free, push token notification, and fingerprint biometrics as authentication options to ensure a fast, efficient workflow.

Imprivata Confirm ID has now collaborated with DigiCert to add an individual identity proofing workflow to its comprehensive, end-to-end EPCS solution. DigiCert enables identity proofing to be done through online verification or declaration of identity verification.

“While Imprivata delivers the end to end authentication for providers, DigiCert delivers authentication for connected devices and the networks and stations that providers connect to,” said Wes Wright, Chief Technology Officer at Imprivata. “Working with DigiCert, we’re now able to offer our customers a full suite of institutional and individual identity proofing solutions.”

The companies say the integration allows Imprivata Confirm ID to bind provider’s identities to the authentication modalities they will use for EPCS, so they can leverage the full suite of authentication options to create a secure and auditable chain of trust.

“Providing multiple authentication options ensures all practitioners can complete the identity proofing process in a timely fashion, especially for individuals who may be unable to complete online verification – for example, if they have issues with their credit history,” said Mike Nelson, VP of IoT at DigiCert. “By integrating seamlessly with our identity proofing process, Imprivata Confirm ID gives customers a single, comprehensive reporting solution to meet the DEA recordkeeping requirements.”

10ZiG recently added support for Imprivata’s fingerprint technology to its Thin & Zero Client healthcare network endpoint series.

Article Topics

authentication  |  biometrics  |  healthcare  |  identity verification  |  Imprivata  |  remote identity proofing